Discovery of small molecule HIV-1 integrase dimerization inhibitors.

Human immunodeficiency virus-1 integrase (HIV-1 IN) inserts the viral DNA into host cell chromatin in a multistep process. This enzyme exists in equilibrium between monomeric, dimeric, tetrameric and high order oligomeric states. However, monomers of IN are not capable of supporting its catalytic functions and the active form has been shown to be at least a dimer. As a consequence, the development of inhibitors targeting IN dimerization constitutes a promising novel antiviral strategy. In this work, we successfully combined different computational techniques in order to identify small molecule inhibitors of IN dimerization. Additionally, a novel AlphaScreen-based IN dimerization assay was used to evaluate the inhibitory activities of the selected compounds. To the best of our knowledge, this study represents the first successful virtual screening and evaluation of small molecule HIV-1 IN dimerization inhibitors, which may serve as attractive hit compounds for the development of novel anti-HIV.

[1]  Thierry Langer,et al.  LigandScout: 3-D Pharmacophores Derived from Protein-Bound Ligands and Their Use as Virtual Screening Filters , 2005, J. Chem. Inf. Model..

[2]  Robert Craigie,et al.  Identification of an inhibitor-binding site to HIV-1 integrase with affinity acetylation and mass spectrometry. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[3]  M. Parker,et al.  Crystal structure of the HIV‐1 integrase core domain in complex with sucrose reveals details of an allosteric inhibitory binding site , 2010, FEBS letters.

[4]  M. Kvaratskhelia,et al.  An Allosteric Mechanism for Inhibiting HIV-1 Integrase with a Small Molecule , 2009, Molecular Pharmacology.

[5]  Z. Debyser,et al.  In search of small molecules blocking interactions between HIV proteins and intracellular cofactors. , 2009, Molecular bioSystems.

[6]  Z. Debyser,et al.  Cellular co-factors of HIV-1 integration. , 2006, Trends in biochemical sciences.

[7]  G. Schneider,et al.  PocketPicker: analysis of ligand binding-sites with shape descriptors , 2007, Chemistry Central Journal.

[8]  A. Voet,et al.  In search of second-generation HIV integrase inhibitors: targeting integration beyond strand transfer. , 2009, Future medicinal chemistry.

[9]  R. Glen,et al.  Molecular recognition of receptor sites using a genetic algorithm with a description of desolvation. , 1995, Journal of molecular biology.

[10]  Xiaohong Liu,et al.  Dithiothreitol causes HIV-1 integrase dimer dissociation while agents interacting with the integrase dimer interface promote dimer formation. , 2011, Biochemistry.

[11]  P Willett,et al.  Development and validation of a genetic algorithm for flexible docking. , 1997, Journal of molecular biology.

[12]  Holger Gohlke,et al.  The Amber biomolecular simulation programs , 2005, J. Comput. Chem..

[13]  P. Kollman,et al.  Calculating structures and free energies of complex molecules: combining molecular mechanics and continuum models. , 2000, Accounts of chemical research.

[14]  Luba Tchertanov,et al.  Resistance to HIV-1 integrase inhibitors: A structural perspective. , 2010, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[15]  D. Burger Raltegravir: a review of its pharmacokinetics, pharmacology and clinical studies , 2010, Expert opinion on drug metabolism & toxicology.

[16]  C. Tintori,et al.  Development of an AlphaScreen-Based HIV-1 Integrase Dimerization Assay for Discovery of Novel Allosteric Inhibitors , 2012, Journal of biomolecular screening.

[17]  C. Tintori,et al.  Exploration of novel thiobarbituric acid-, rhodanine- and thiohydantoin-based HIV-1 integrase inhibitors. , 2009, Bioorganic & medicinal chemistry letters.

[18]  Martin Sippel,et al.  Molecular Dynamics Simulations of the HIV-1 Integrase Dimerization Interface: Guidelines for the Design of a Novel Class of Integrase Inhibitors , 2010, J. Chem. Inf. Model..

[19]  Zeger Debyser,et al.  Transportin-SR2 Imports HIV into the Nucleus , 2008, Current Biology.

[20]  C. Brullo,et al.  Inhibition of Bcr‐Abl Phosphorylation and Induction of Apoptosis by Pyrazolo[3,4‐d]pyrimidines in Human Leukemia Cells , 2007, ChemMedChem.

[21]  J. Mouscadet,et al.  Peptide inhibitors of HIV-1 integrase dissociate the enzyme oligomers. , 2001, Biochemistry.

[22]  M. Parker,et al.  Fragment‐Based Design of Ligands Targeting a Novel Site on the Integrase Enzyme of Human Immunodeficiency Virus 1 , 2011, ChemMedChem.

[23]  Laith Q Al-Mawsawi,et al.  Allosteric Inhibitor Development Targeting HIV‐1 Integrase , 2011, ChemMedChem.

[24]  C. Tintori,et al.  A Versatile and Practical Synthesis toward the Development of Novel HIV‐1 Integrase Inhibitors , 2011, ChemMedChem.

[25]  S. Ferro,et al.  Inhibition of the interaction between HIV-1 integrase and its cofactor LEDGF/p75: a promising approach in anti-retroviral therapy. , 2011, Mini reviews in medicinal chemistry.

[26]  Hualiang Jiang,et al.  Symmetrical 1-pyrrolidineacetamide showing anti-HIV activity through a new binding site on HIV-1 integrase , 2008, Acta Pharmacologica Sinica.

[27]  A. Saïb,et al.  Integrase and integration: biochemical activities of HIV-1 integrase , 2008, Retrovirology.

[28]  S. Boyd Management of HIV infection in treatment-naive patients: a review of the most current recommendations. , 2011, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[29]  A. Marchand,et al.  Rational design of small-molecule inhibitors of the LEDGF/p75-integrase interaction and HIV replication. , 2010, Nature chemical biology.

[30]  M. Shultz,et al.  Interfacial peptide inhibitors of HIV-1 integrase activity and dimerization. , 2003, Bioorganic & medicinal chemistry letters.

[31]  Richard D. Taylor,et al.  Improved protein–ligand docking using GOLD , 2003, Proteins.

[32]  E. Guiot,et al.  Relationship between the Oligomeric Status of HIV-1 Integrase on DNA and Enzymatic Activity* , 2006, Journal of Biological Chemistry.

[33]  A. Engelman,et al.  Retroviral intasome assembly and inhibition of DNA strand transfer , 2010, Nature.